FeesSafety
Pluang+

JPM Coin launched on Ethereum with no supply or transfers days after institutional rollout

Protocol Fundamentals
24 Oct 2026
Tokenpost
View Source
Neutral
JPM Coin launched on Ethereum with no supply or transfers days after institutional rollout

J.P. Morgan introduced its JPM Coin (JPMD) on the Ethereum blockchain on October 19, extending its availability beyond the Base network. As of October 22, JPMD showed no supply or recorded transfers on Ethereum, with only one address on its allowlist. On Base, the token supply remained steady at about 1 million tokens, representing U.S. dollar deposits held by J.P. Morgan for approved institutional clients. The bank has not disclosed public transaction volumes, and same-day token issuance and redemption can keep supply numbers unchanged, indicating limited visible activity on Ethereum so far.

JPM Coin's activity on Ethereum is noted here as context for readers. As of October 24, 2026, 5 out of 50 major cryptocurrencies on Pluang rose while 43 fell. Among these, EOS gained 8.13% to Rp12.649, BAT dropped 8.76% to Rp2.874 with 84% of orders selling, and ONE fell 7.43% to Rp24 with 97% of orders buying, as of 17:51 WIB.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
1 hour ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
1 hour ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
3 hours ago
BlackRock TCP Capital remains a sell amid structural challenges despite high dividend yield.

BlackRock TCP Capital remains a sell amid structural challenges despite high dividend yield.

BlackRock TCP Capital (TCPC) continues to face structural issues and sector headwinds, leading to a sell recommendation despite trading at a deep discount to its net asset value (NAV). The company has restructured its portfolio, including a significa...

Market News
Bearish
4 hours ago
Blockstream opens Swiss office to offer Bitcoin infrastructure consulting for European financial firms

Blockstream opens Swiss office to offer Bitcoin infrastructure consulting for European financial firms

Blockstream has opened a new office in Lugano, Switzerland, launching consulting services to help banks and asset managers design and implement Bitcoin infrastructure. The service covers technical planning, system architecture, and integration for pr...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App